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The impact of conversion to international 
Classification of Diseases, 10th revision (ICD-10) 
on an academic ophthalmology practice
Justin B hellman
Michele C lim
Karen Y leung
Cameron M Blount
glenn Yiu
Department of Ophthalmology & 
Vision Sciences, University of 
California, Davis Medical Center, 
Sacramento, CA, USA
Purpose: To determine the financial and clinical impact of conversion from International 
Classification of Disease, 9th revision (ICD-9) to ICD-10 coding.
Design: Retrospective, database study.
Materials and methods: Monthly billing and coding data from 44,564 billable patient encoun-
ters at an academic ophthalmology practice were analyzed by subspecialty in the 1-year periods 
before (October 1, 2014, to September 30, 2015) and after (October 1, 2015, to September 30, 
2016) conversion from ICD-9 to ICD-10.
Main outcomes and measures: Primary outcome measures were payments per visit, relative 
value units per visit, number of visits, and percentage of high-level visits; secondary measures 
were denials due to coding errors, charges denied due to coding errors, and percentage of 
unspecified codes used as a primary diagnosis code.
Results: Conversion to ICD-10 did not significantly impact payments per visit ($306.56±$56.50 
vs $321.43±$38.12, P=0.42), relative value units per visit (7.15±0.56 vs 7.13±0.84, P=0.95), 
mean volume of visits (1,887.08±375.02 vs 1,863.83±189.81, P=0.71), or percentage of 
high-level visits (29.7%±4.9%, 548 of 1,881 vs 30.0%±1.7%, 558 of 1,864, P=0.81). For 
every 100 visits, the number of coding-related denials increased from 0.98±0.60 to 1.84±0.31 
(P,0.001), and denied charges increased from $307.42±$443.39 to $660.86±$239.47 (P=0.002). 
The monthly percentage of unspecified codes used increased from 25.8%±1.1% (485 of 1,881) 
to 35.0%±2.3% (653 of 1,864, P,0.001).
Conclusion: The conversion to ICD-10 did not impact overall revenue or clinical volume in 
this practice setting, but coding-related denials, denied charges, and the use of unspecified codes 
increased significantly. We expect these denials to increase in the next year in the absence of 
Medicare’s 1-year grace period.
Keywords: ICD-10, ICD-9, ICD International Classification of Diseases, ophthalmology, 
electronic health records, clinical coding, medical records, reimbursement
Introduction
The conversion from the International Classification of Diseases, 9th revision, Clinical 
Modification (ICD-9-CM) to ICD-10-CM was the largest change to health care coding 
in America in the last 30 years.1 While ICD-10 was approved in 1990 and had been 
utilized in several countries since as early as 1994, its use only became required in the 
United States on October 1, 2015. The version used in the United States has several 
significant modifications suggested during an open comment period and via a field test 
performed by The American Hospital Association and the American Health Information 
Management Association. ICD-10-CM, as the version is known, added many more 
Correspondence: glenn Yiu
Department of Ophthalmology & Vision 
Sciences, University of California, Davis 
Health, 4860 Y Street, Suite 2400, 
Sacramento, CA 95817, USA
Tel +1 916 734 6602
email gyiu@ucdavis.edu 
Journal name: Clinical Ophthalmology
Article Designation: Original Research
Year: 2018
Volume: 12
Running head verso: Hellman et al
Running head recto: Impact of conversion to ICD-10 on an ophthalmology practice
DOI: 161742
Clinical Ophthalmology 2018:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
950
hellman et al
codes than the original World Health Organization version 
used prior to adoption in the United States.2,3 The Depart-
ment of Health and Human Services originally planned to 
instate ICD-10 on October 1, 2011, but its implementation 
met resistance. The American Medical Association feared 
that the costs of implementing ICD-10 would be extreme and 
could even put smaller practices out of business.1 In 2009, 
the Department of Health and Human Services changed the 
date to October 1, 2013.4 Two additional delays led to the 
final implementation date of October 1, 2015.5
Each ICD-10 code has space for seven characters, an 
increase from the five available in ICD-9.6 The nearly 70,000 
diagnostic codes available in ICD-10 provide a much greater 
level of detail than the 14,500 codes available in ICD-9, and 
mapping diagnoses from one to the other is often convoluted 
and rarely straightforward.7 Included in the increased details 
are codes that specify laterality and severity of disease, 
features that have a substantial effect on coding in ophthal-
mology. The increased level of detail is projected to lead 
to an eventual decrease in denied claims.8,9 Unfortunately, 
this decrease in rejected claims is expected to occur after a 
period of increased rejected claims lasting from 6 months 
to 3 years as coders adapt to the new system.8,10–12 The more 
detailed information available from ICD-10 codes is also 
predicted to more easily identify fraud and abuse, give insur-
ance companies more accurate information in order to make 
coverage decisions, and improve public health monitoring 
and research.7,10 Notably a dually coded database in Canada 
showed no improvement in the validity of coding with 
ICD-10 compared to ICD-9.11 However, a Swedish study did 
show continual improvement in the accuracy of recording 
conditions using ICD-10 over a 5-year period related to a 
coding learning curve.12
The key concern about ICD-10 has always been 
cost.9,10,13,14 The most recent Nachimson Advisors analysis 
estimated that a small practice (3 physicians, 2 administrators) 
would lose between $56,639 and $226,105 through additional 
training, software upgrades, testing, productivity loss, and 
payment disruption. A medium-sized practice (10 physicians, 
1 coder, 6 administrators) was projected to lose $213,364 to 
$824,735, and a large practice (100 physicians, 10 coders, 
and 64 administrators) was projected to lose $2,017,151 to 
$8,018,364. The largest portion of these losses was projected 
to be due to productivity loss and disruptions in payment. 
These predictions were for physicians in general and not 
targeted toward any specific specialty.14
In this study, we aim to determine the clinical and 
financial impacts of conversion to ICD-10 on an academic 
multispecialty ophthalmology practice with a well-established 
electronic health record (EHR) system. Since the addition of 
laterality to codes is a significant change and ocular condi-
tions are almost uniformly lateralized, we hypothesized that 
the conversion may negatively impact eye care providers. 
We also investigated whether the increasing complexity of 
coding some common ophthalmologic diagnoses would lead 
to more frequent use of unspecified codes.
Materials and methods
We performed a retrospective database study of deidentified 
billing records at the University of California (UC), Davis 
Eye Center in Sacramento, CA. The study protocol followed 
the tenets of the Declaration of Helsinki and was exempted 
from approval by the university’s Institutional Review Board 
Committee as the work was not considered human subject 
research as defined by federal regulation 45 CFR 46.102. 
Our practice consisted of 16 ophthalmologists and included 
specialists in cornea, glaucoma, neuro-ophthalmology, 
oculoplastics, pediatrics, and retina. Optometrists, ophthal-
mology trainees, and part-time volunteer clinical faculty 
were not included in the analysis. Over the 2 years of the 
study, the medical staff was unchanged with the exception 
of the following: 1) a comprehensive ophthalmologist was 
on sabbatical and worked only part time before June 2015; 
2) a neuro-ophthalmologist left the practice in 2015 and was 
immediately replaced by another neuro-ophthalmologist who 
saw fewer patients each month; and 3) a retina specialist was 
hired into the practice 2 months after the beginning of the 
study period. These three providers were excluded from the 
analysis to avoid the confounding effect of changes in their 
clinical volume.
ICD-10 implementation strategy
In our practice, a team of ophthalmic coding specialists reviews 
and analyzes all patient charts after visits are completed and 
assigns the coding information for medical billing. From 
July 1, 2014, until the official implementation of ICD-10, the 
coders utilized both ICD-9 and ICD-10 codes for additional 
training. The coding staff remained unchanged throughout the 
course of the study period, and no additional compensation 
was provided to the coders during the transition period. These 
figures do not include the cost of software implementation 
to the EHR system, which took place across the university 
medical center prior to ICD-10 implementation.
Financial and clinical impacts
To analyze the changes in clinical revenue and productivity 
after ICD-10 conversion, we obtained billing summaries 
from the UC Davis Eye Center from October 1, 2014, to 
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September 30, 2016, and examined the mean payments per 
visit, relative value units (RVUs) per visit, number of visits, 
and percentage of high-level visits for each month during the 
12-month periods before and after ICD-10 implementation on 
October 1, 2015. High-level visits were defined by Current 
Procedural Terminology codes 99204, 99205, 92004, 99214, 
99215, and 92014. Low-level visit codes were defined by 
Current Procedural Terminology codes 99201–99203, 99243, 
92002, 99211–99213, and 92012. We also evaluated the 
number of coding-related denials and average denied charges 
per 100 visits, as well as denied charges as a percentage of 
total charges during the two periods. Coding-related denials 
were defined as insurance claims that were denied due to 
an error in coding. Finally, we assessed coder efficiency by 
comparing the percentage of charges coded within 10 days 
of a visit before and after ICD-10 implementation.
Coding behavior
To evaluate the increased complexity of ICD-10 coding as 
a potential cause of increased insurance claim denials, we 
identified the top 15 primary ICD-9 codes used between 
October 1, 2014, and September 30, 2015. We then assessed 
the corresponding section of ICD-10 to identify all of the 
possible corresponding codes. To determine if the increased 
complexity of ICD-10 resulted in more frequent use of 
unspecified diagnosis codes, we analyzed the total volume of 
ICD-9 and ICD-10 codes used as primary diagnoses during 
the 12-month period before and after ICD-10 implementation 
and compared the proportion of specified and unspecified 
codes and their distribution among subspecialty categories. 
We also analyzed which categories of unspecified codes were 
used most frequently.
ICD-9 codes were categorized based on blocks in Chapter 6 
of the 2016 edition of the ICD-9-CM manual. ICD-10 codes 
were categorized similarly based on blocks in Chapter 7 
of the 2016 edition of the ICD-10-CM manual (Table 1). 
Unspecified codes were defined as codes with the term 
“unspecified” in the name where more specific codes exist 
that could have been used in their place.
statistical analysis
We stored and analyzed the data using Microsoft Excel for 
Mac 2011 with the Real Statistics Resource Pack and Statisti-
cal Package for the Social Sciences (SPSS). Normality of all 
data distributions were confirmed with the Shapiro–Wilk test. 
If normality held, we utilized two-tailed Student’s t-tests, and 
we used a Wilcoxon Rank-Sum Test for variables that did not 
follow a normal distribution. Data were reported as mean ± 
standard deviation. We performed the Benjamini–Hochberg 
procedure on each group of tests, separated by department, 
to control false discovery rate with a q value of 0.05.
Ethics approval and informed 
consent
The study protocol followed the tenets of the Declaration of 
Helsinki and was exempted from approval by the University 
of California Davis Institutional Review Board Committee.
Results
When comparing 12 months of data before and after conver-
sion to ICD-10, we noted no significant change in payments 
per visit ($306.56±$56.50 vs $321.43±$38.12, P=0.42), 
RVUs per visit (7.15±0.56 vs 7.13±0.84, P=0.95), mean 
volume of visits (1,887.08±375.02 vs 1,863.83±189.81, 
P=0.71), or percentage of high-level visits (29.7%±4.9%, 548 
of 1,881 per month vs 30.0%±1.7%, 558 of 1,864 per month, 
P=0.81). However, when comparing changes in denial-related 
metrics before and after conversion to ICD-10, there were 
nearly twofold increases in coding-related denials per 100 
visits (0.98±0.60 vs 1.84±0.31; P,0.001), charges denied per 
100 visits ($307.42±$443.39 vs $660.86±$239.47; P=0.002), 
and percentage of total charges denied (0.35%±0.51%, 
Table 1 Categorization of ICD-9 and ICD-10 codes
ICD-9 codes ICD-10 codes Category
360.XX–363.XX, 250.XX H30.XXX–H36.XXX, H43.XXX–H44.XXX, 
E08.XXX–E13.XXX
retina
364.XX, 370.XX–372.XX, 54.43, 375.15 H10.XXX–H11.XXX, H04.12, 
H15.XXX–H22.XXX, B00.52
Cornea
365.XX H40.XXX–H42.XXX, Q15.0 glaucoma
366.XX H25.XXX–H28.XXX Cataract
367.XX H52.XXX refractive
373.XX–376.XX except 375.15 H00.XXX–H05.XXX except H04.12 Oculoplastics
368.XX, 369.XX, 377.XX, 378.XX H46.XXX–H47.XXX, H49.XXX–H51.XXX, 
H53.XXX–H54.XXX
Pediatric/neuro-ophthalmology
V45, V58, V67, 996.51 H59.XXX, Z09 Perioperative 
Abbreviation: ICD, International Classification of Diseases.
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$5,556.50 of $1,581,345 vs 0.74%±0.30%, $12,567.33 of 
$1,701,466; P=0.002).
When analyzing the same data by subspecialties, we found 
no significant change in payments per visit, RVUs per visit, 
number of visits, or percentage of high-level visits in any 
group after ICD-10 conversion, with the exception of com-
prehensive ophthalmology, which showed a slight increase 
in percentage of high-level visits (Table 2). All subspecialties 
Table 2 Clinical and financial impacts of ICD-10 conversion by subspecialties in ophthalmology
Subspecialty Pre ICD-10 Post ICD-10 P-value
Cornea
Payments/visit $231.49±$47.09 $229.65±$44.21 0.93
RVUs/visit 5.49±0.70 5.27±0.99 0.60
Visits 451.33±107.14 437.08±76.33 0.75
Percentage of high-level visits 19.2%±3.2% 17.1%±3.9% 0.18
Coding-related denials per 100 visits 0.63±0.75 1.69±0.61 0.004
Charges denied per 100 visits $240.48±$639.13 $289.78±$143.36 0.002
Percentage of charges denied 0.42%±1.12% 0.49%±0.32% 0.001
Comprehensive
Payments/visit $723.78±$322.73 $800.84±$337.97 0.39
RVUs/visit 14.77±4.85 15.88±3.97 0.27
Visits 100.17±26.27 89.83±24.49 0.41
Percentage of high-level visits 49.8%±6.7% 56.7%±15.0% 0.01
Coding-related denials per 100 visits 0.79±0.93 3.80±2.90 0.001
Charges denied per 100 visits $191.78±$364.23 $1,310.71±$1,252.38 0.01
Percentage of charges denied 0.12%±0.20% 0.74%±0.76% 0.01
Glaucoma
Payments/visit $250.14±$71.33 $230.45±$31.45 0.33
RVUs/visit 5.66±0.74 5.28±0.60 0.21
Visits 515.42±181.92 530.42±67.78 0.23
Percentage of high-level visits 14.9%±2.9% 16.8%±2.6% 0.08
Coding-related denials per 100 visits 0.92±0.61 1.26±0.66 0.23
Charges denied per 100 visits $301.18±$711.09 $644.85±$634.95 0.03
Percentage of charges denied 0.49%±1.18% 0.99%±0.99% 0.03
Oculoplastics
Payments/visit $778.34±$243.99 $873.56±$315.65 0.27
RVUs/visit 18.40±6.07 17.48±4.53 0.70
Visits 76.08±19.37 74.33±15.85 0.72
Percentage of high-level visits 4.7%±3.3% 4.8%±2.8% 0.93
Coding-related denials per 100 visits 0.59±0.93 1.33±1.28 0.17
Charges denied per 100 visits $512.62±$975.00 $1,700.31±$2,063.10 0.06
Percentage of charges denied 0.34%±0.68% 0.54%±0.72% 0.20
Pediatrics
Payments/visit $176.53±$55.18 $185.40±$36.04 0.65
RVUs/visit 4.43±0.33 4.52±0.50 0.53
Visits 329.92±54.83 326.42±47.99 0.86
Percentage of high-level visits 34.3%±7.7% 38.1%±7.7% 0.27
Coding-related denials per 100 visits 1.75±1.18 2.33±1.20 0.31
Charges denied per 100 visits $416.36±$565.82 $504.72±$446.95 0.25
Percentage of charges denied 0.84%±1.04% 0.93%±0.77% 0.42
Retina
Payments/visit $409.50±$89.89 $472.87±$86.00 0.18
RVUs/visit 9.64±1.37 10.21±2.17 0.73
Visits 414.17±91.71 405.75±69.04 0.95
Percentage of high-level visits 53.2%±15.3% 52.9%±7.6% 0.96
Coding-related denials per 100 visits 0.94±0.78 2.15±1.00 0.001
Charges denied per 100 visits $309.66±$406.86 $932.40±$772.08 0.02
Percentage of charges denied 0.24%±0.31% 0.66%±0.55% 0.02
Note: Values expressed as monthly mean ± standard deviation.
Abbreviations: ICD, International Classification of Diseases; RVUs, relative value units.
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experienced an increase in coding-related denials and denied 
charges, but only higher-volume services including compre-
hensive, cornea, and retina reached statistical significance 
(Table 2).
After identifying the top 15 primary visit diagnosis ICD-9 
codes used in the 12-month period before ICD-10 implemen-
tation, we found a total of 153 possible corresponding ICD-10 
codes. There were only 3 one-to-one mappings, where there 
was only one ICD-10 code that corresponded with the ICD-9 
code in question. For 2 of those, exudative and nonexudative 
senile macular degeneration, the current version of ICD-10 
requires much greater specificity than was required during 
the study period (Table 3).
The overall monthly percentage of unspecified codes used 
increased from 25.8%±1.1% (485 of 1,881) in the ICD-9 
period to 35.0%±2.3% (653 of 1,864) after ICD-10 imple-
mentation (P,0.001). Significant increases in the percentage 
of unspecified codes were seen in glaucoma (P,0.001), other 
(P,0.001), pediatrics/neuro-ophthalmology (P,0.001), 
perioperative (P=0.01), oculoplastics (P=0.003), and refrac-
tive (P,0.001) diagnoses. Cataract (P,0.001) and cornea 
(P,0.001) showed significant decreases in percentage of 
unspecified codes used, and there were no significant changes 
in retina (P=0.025) diagnoses. The biggest changes were seen 
in glaucoma and refractive diagnoses (Figure 1). Codes were 
most often considered unspecified due to lack of laterality, 
disease type, or stage (Table 4).
There was no overall difference in coder efficiency in 
the 1-year periods before and after ICD-10 implementation 
(P=0.76). However, we noted a reduction in coder efficiency 
during the first 4 months (October 2015 to January 2016) 
after ICD-10 conversion, which returned to baseline for the 
remaining 8 months (Figure 2).
Discussion
Our study found no change in financial and clinical produc-
tivity for a mid-sized ophthalmology practice after conver-
sion to ICD-10 in terms of total revenue, RVUs, patient 
volume, and percentage of high-level visits. Although billing 
claim denials nearly doubled after ICD-10 conversion, the 
associated financial loss to the practice was only 0.73% of 
total charges. Denied charges due to coding errors increased 
across nearly all subspecialties. A possible explanation for 
the increase in denials is the increased complexity of ICD-10, 
which may result in a higher probability of coding errors or 
an increased use of unspecified codes. From the 15 most 
common ICD-9 codes used in our practice, we noted a 
more than 10-fold increase in corresponding ICD-10 codes 
(Table 3). This increased complexity likely led to the substan-
tial increase in the use of unspecified ICD-10 codes, which 
occurred across several of the ophthalmic subspecialties.
Our findings contrast with data released by the Centers 
for Medicare and Medicaid Services (CMS) in 2015 which 
show that in the fourth quarter, the total number of submitted 
claims, rejected claims, and denied claims had not changed in 
the 3 months after switching to ICD-10.15 Their findings may 
be due to the 1-year grace period after ICD-10 implementa-
tion during which CMS stated that “Medicare review con-
tractors will not deny physician or other practitioner claims 
billed under the Part B physician fee schedule through either 
automated medical review or complex medical record review 
based solely on the specificity of the ICD-10 diagnosis code 
as long as the physician/practitioner used a valid code from 
the right family.”16 Despite this grace period, our study did 
show an increase in denied payments due to coding errors. 
Table 3 Fifteen most commonly used ICD-9 codes and possible 
corresponding ICD-10 codes
Most commonly used 
ICD-9 codes
Number 
of possible 
corresponding 
ICD-10 codes
Possible 
corresponding 
ICD-10 codes
365.11: Primary open-angle 
glaucoma
5 (20) H40.11XX
365.00: Preglaucoma, unspecified 28 H40.0XX
V67.09: Follow-up examination, 
following other surgery
1 Z09
250.50: Diabetes mellitus with 
ophthalmic manifestations, 
type II or unspecified, not stated 
as uncontrolled
15 (56) E11.3XX
365.04: Ocular hypertension 8 H40.0XX
362.52: Exudative senile macular 
degeneration
1 (16) H35.32
366.19: Other and combined 
forms of senile cataract
10 H25.XXX
375.15: Tear film insufficiency, 
unspecified
4 H04.12X
362.51: Nonexudative senile 
macular degeneration
1 (20) H35.31XX
378.35: Accommodative 
component in esotropia
1 H50.43
364.3: Unspecified iridocyclitis 38 H20.XXX
378.00: Esotropia, unspecified 13 H50.0XX
362.56: Macular puckering 4 H35.37X
365.12: Low tension open-angle 
glaucoma
20 H40.12XX
362.53: Cystoid macular 
degeneration
4 H35.35X
Notes: Values in parentheses indicate number of possible codes after October 1, 
2016, which is outside the study period. X indicates the subclassification of the 
ICD-10 code.
Abbreviation: ICD, International Classification of Diseases.
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Furthermore, since October 1, 2016, CMS review contractors 
can use coding specificity as the reason for an audit, and this 
may lead to a further increase in denied claims.
Nachimson Advisors predicted $147,912 to $501,147 
in productivity loss and payment disruption; however, 
these predictions do not account for the CMS grace period. 
With regard to clinical productivity, increased time for 
documentation and code selection was projected to increase 
office visit times by 15%.14 Our practice did not experi-
ence any significant impact on clinical volume, likely due 
in part to the employment of a certified coding team in our 
practice which allows the physicians to spend less time on 
coding than in other practice settings. Although we noted 
an early reduction in coder efficiency in the first 4 months 
after ICD-10 implementation (Figure 2), the overall impact 
at 1 year was minimal.
A limitation of this study is that we could not calculate 
the cost of implementing new software and hardware systems 
for ICD-10 conversion. Nachimson Advisors predicted that 
a practice of our size would spend $213,364 to $824,735 in 
preimplementation costs.14 While our practice spent only 
approximately $2,000 for educational materials and coder 
Table 4 Most commonly used unspecified ICD-10 codes and the missing specification
Unspecified code Frequency of use as 
primary diagnosis
Missing specification
Primary open-angle glaucoma, stage unspecified 998 stage
Preglaucoma, unspecified, bilateral 817 Open or narrow angle
Unspecified esotropia 303 Monocular or alternating, pattern
Unspecified intermittent heterotropia 286 esotropia or exotropia
Preglaucoma unspecified, unspecified eye 279 Laterality, open or narrow angle
Unspecified iridocyclitis 261 Primary, recurrent, chronic, or 
secondary, laterality
Unspecified corneal scar and opacity 221 Central or peripheral, laterality 
Unspecified glaucoma 187 Type, laterality or stage
Ocular hypertension, unspecified eye 154 laterality
Keratoconus, unspecified, bilateral 132 stable or unstable
Unspecified exotropia 130 Monocular or alternating, pattern
Unspecified amblyopia, right eye 116 Type
Unspecified amblyopia, left eye 101 Type
Abbreviation: ICD, International Classification of Diseases.
Figure 1 Proportion of unspecified ICD-9 and ICD-10 codes at the University of California Davis Eye Center between October 1, 2014, and September 30, 2016, categorized 
by diagnosis type.
Abbreviations: ICD, International Classification of Diseases; Neuro/peds, neuro-ophthalmology and pediatric ophthalmology.
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Figure 2 Line graph showing the monthly percentage of transactions coded within 10 days of the visit over the 12-month period following ICD-10 conversion.
Abbreviation: ICD, International Classification of Diseases.
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training, the cost of upgrading our EHR system to implement 
ICD-10 was provided by the UC Davis Health System, and 
the portion of this cost associated with ophthalmology could 
not be determined. Another study limitation is that we did not 
address the use of secondary diagnosis codes or number of 
codes per patient, and therefore an analysis of the financial 
impact independent of the ICD-10 codes assigned could 
not be performed. In addition, since this study compares 
two different years of practice, it is possible that trends in 
cases over the study period may have influenced our results. 
Finally, our study reflects the financial impact of ICD-10 
conversion on a medium-sized multispecialty ophthalmology 
practice in a university setting, and the findings may not 
readily apply to other practice settings.
Future studies should account for additional changes imple-
mented in ICD-10 for ophthalmology since October 1, 2016. 
Specifically, open-angle glaucoma and diabetic retinopathy 
diagnoses now require specification of laterality. Nonexuda-
tive age-related macular degeneration requires severity and 
laterality to be specified. Exudative age-related macular 
degeneration requires specification of whether there is active 
choroidal neovascularization, inactive choroidal neovascu-
larization, or an inactive scar.17 Finally, retinal vein occlu-
sions require specification of whether macular edema or 
retinal neovascularization are present. This further increase 
in specificity may have impacts in the second year after 
ICD-10 conversion.
Conclusion
The conversion to ICD-10 has added a much greater level 
of detail and specificity to coding in ophthalmology. The 
increase in complexity may have contributed to the increased 
percentage of unspecified codes used in our practice. It is 
not clear why we found an increase in coding-related deni-
als and denied charges after conversion to ICD-10 during a 
grace period in which the use of unspecified codes should 
not have been penalized by CMS. Nevertheless, ICD-10 
implementation did not significantly affect overall financial 
or clinical productivity over 12 months.
Data availability
Data is available by request from the corresponding author.
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